Which receptor mediates norepinephrine's vascular effects?

Which receptor mediates norepinephrine's vascular effects?

• A. Alpha-1 mediated vasoconstriction
• B. Beta-2 mediated vasodilation
• C. Dopaminergic vasodilation
• D. Beta-3 mediated vasodilation

Answer: (A)

Norepinephrine’s vascular effect is driven primarily by alpha-1 adrenergic receptor activation on vascular smooth muscle, which causes vasoconstriction through increased intracellular calcium and muscle contraction. This alpha-1–mediated constriction raises systemic vascular resistance and blood pressure. Beta-2–mediated vasodilation is more characteristic of epinephrine’s action in certain beds (like skeletal muscle) and is not a major driver for norepinephrine. Dopaminergic vasodilation involves dopamine receptors in specific regions (e.g., renal vessels) and is not the central mechanism of norepinephrine’s vascular effects. Beta-3–mediated vasodilation is not a typical pathway for norepinephrine in systemic vasculature. Therefore, alpha-1–mediated vasoconstriction best explains norepinephrine’s vascular effects.

Norepinephrine’s vascular effect is driven primarily by alpha-1 adrenergic receptor activation on vascular smooth muscle, which causes vasoconstriction through increased intracellular calcium and muscle contraction. This alpha-1–mediated constriction raises systemic vascular resistance and blood pressure. Beta-2–mediated vasodilation is more characteristic of epinephrine’s action in certain beds (like skeletal muscle) and is not a major driver for norepinephrine. Dopaminergic vasodilation involves dopamine receptors in specific regions (e.g., renal vessels) and is not the central mechanism of norepinephrine’s vascular effects. Beta-3–mediated vasodilation is not a typical pathway for norepinephrine in systemic vasculature. Therefore, alpha-1–mediated vasoconstriction best explains norepinephrine’s vascular effects.